Inspire Medical Systems
INSP
155 hedge funds and large institutions have $1.33B invested in Inspire Medical Systems in 2019 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 48 increasing their positions, 51 reducing their positions, and 21 closing their positions.
2,280% more call options, than puts
Call options by funds: $53.5M | Put options by funds: $2.25M
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
33% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 21
10% more capital invested
Capital invested by funds: $1.21B → $1.33B (+$120M)
7.37% more ownership
Funds ownership: 83.87% → 91.24% (+7.4%)
5% more funds holding
Funds holding: 148 → 155 (+7)
6% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 51
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$38.8M |
| 2 |
BlackRock
New York
|
+$34.4M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$20.4M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$19.5M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$19.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$14M |
| 2 |
Millennium Management
New York
|
-$9.46M |
| 3 |
DM
Deerfield Management
New York
|
-$9.16M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.57M |
| 5 |
SIM
Spark Investment Management
New York
|
-$4.89M |
INSP Hedge Fund Activity: Q3 2019 in Review
155 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q3 2019, worth a combined $1.33B — up 9.9% from $1.21B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new INSP positions and 21 closed out — a net gain of 7 holders — while 48 added to existing stakes and 51 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $38.8M. The largest seller was Citadel Advisors, cutting an estimated $14M.
- 155 institutional investors held Inspire Medical Systems (INSP) as of Q3 2019, up from 148 in Q2 2019.
- Funds reported $1.33B of Inspire Medical Systems stock for Q3 2019, up 9.9% quarter-over-quarter.
- 28 funds opened new Inspire Medical Systems positions in Q3 2019 and 21 closed out, a net change of +7 holders.
- The largest Inspire Medical Systems buyer in Q3 2019 was Morgan Stanley, an estimated $38.8M added.
- The largest Inspire Medical Systems seller in Q3 2019 was Citadel Advisors, an estimated $14M sold.
Based on aggregated 13F filings for Q3 2019.